IndexIQ Advisors’s AbbVie ABBV Stock Holding History

IndexIQ Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$8.33M	Buy	51,398 +21,494	+72%	+$3.12M	0.29%	72
2021 Q4	$4.05M	Sell	29,904 -305	-1%	-$36K	0.14%	131
2021 Q3	$3.26M	Buy	30,209 +1,521	+5%	+$174K	0.11%	171
2021 Q2	$3.23M	Buy	28,688 +745	+3%	+$83.9K	0.11%	169
2021 Q1	$3.02M	Sell	27,943 -21,629	-44%	-$2.31M	0.11%	163
2020 Q4	$5.31M	Buy	49,572 +11,573	+30%	+$1.11M	0.2%	75
2020 Q3	$3.33M	Buy	37,999 +7,808	+26%	+$735K	0.14%	99
2020 Q2	$2.96M	Buy	30,191 +3,433	+13%	+$302K	0.13%	91
2020 Q1	$2.04M	Sell	26,758 -25,629	-49%	-$2.18M	0.09%	100
2019 Q4	$4.64M	Buy	52,387 +11,760	+29%	+$976K	0.17%	122
2019 Q3	$3.08M	Sell	40,627 -13,897	-25%	-$953K	0.11%	153
2019 Q2	$3.96M	Sell	54,524 -1,092	-2%	-$85.8K	0.12%	142
2019 Q1	$4.48M	Buy	+55,616	New	+$4.55M	0.13%	112

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IndexIQ Advisors's ABBV Position: Q1 2022 in Review

IndexIQ Advisors increased its AbbVie (ABBV) stake by 72% in Q1 2022, buying an estimated $3.12M and bringing the position to 51,398 shares worth $8.33M. The position accounts for 0.29% of the portfolio, ranked #72.

IndexIQ Advisors first reported a position in ABBV in Q1 2019 and has held it in 13 quarters since. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

IndexIQ Advisors held 51,398 shares of AbbVie worth $8.33M as of Q1 2022.
IndexIQ Advisors bought 21,494 AbbVie shares in Q1 2022, an estimated $3.12M.
AbbVie made up 0.29% of IndexIQ Advisors's portfolio in Q1 2022, its #72 holding.
IndexIQ Advisors first reported a position in AbbVie in Q1 2019 and has held it in 13 quarters since.
3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.